Providing Better-Matched Donors for HLA Mismatched Compatible Pairs Through Kidney Paired Donation

Paolo Ferrari1, Linda Cantwell, Joseph Ta

  • 11 Department of Nephrology and Transplantation, Prince of Wales Hospital, Sydney, NSW, Australia. 2 Clinical School, University of New South Wales, Sydney, Australia. 3 Victorian Transplantation and Immunogenetics Service, Australian Red Cross Blood Service, Melbourne, Victoria, Australia. 4 Department of Clinical Immunology, Fiona Stanley Hospital, Mudroch, WA, Australia. 5 School of Pathology and Laboratory Medicine, University of Western Australia, Perth, Australia.

Transplantation
|April 15, 2016
PubMed

Insights

Compatible pairs (CP) in kidney paired donation (KPD) can improve HLA matching for recipients with high mismatches. This strategy also enhances donation rates for incompatible pairs (ICP) without compromising their outcomes.

Area of Science:

  • Nephrology
  • Immunology
  • Transplantation Science

Background:

  • Kidney paired donation (KPD) programs traditionally serve incompatible pairs (ICP).
  • Compatible pairs (CP) with high HLA mismatches may benefit from KPD if better matches are prioritized.
  • Allocation metrics are needed to integrate CPs into KPD without disadvantaging ICPs.

Purpose of the Study:

  • To evaluate the impact of compatible pair participation on HLA matching for both compatible and incompatible recipients within KPD simulations.
  • To define allocation strategies that benefit CP recipients while ensuring no negative consequences for ICPs.

Main Methods:

  • Simulations using the Australian KPD matching algorithm with 46 ICPs and 11 CPs.
  • CPs were added individually or collectively, with and without exclusion of unacceptable antigens (70-80% virtual calculated panel-reactive antibody).

Main Results:

  • CP recipients achieved significantly lower eplet mismatch (EpMM) compared to their own donors (57 ± 15 vs. 78 ± 19).
  • Significant EpMM reduction was observed for CP recipients with an initial EpMM > 65.
  • Including CPs increased ICP matching rates by up to 50%.

Conclusions:

  • CP participation in KPD can improve HLA matching for CP recipients with high EpMM.
  • KPD allocation strategies incorporating CPs enhance match rates for ICPs.
  • Virtual crossmatch-based allocation benefits CP recipients and increases overall KPD efficiency.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
679
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
739
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.3K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K